| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736714 | The Brazilian Journal of Infectious Diseases | 2018 | 10 Pages |
Abstract
All three models predicted a cost per quality-adjusted life year gained for quadrivalent versus trivalent influenza vaccine in the range of R$19,257 (FLORENCE) to R$22,768 (FLORA) with the best available data in Brazil (Appendix A).
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Laure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, Jorge Gomez, Ilse Van Vlaenderen,